Events or circumstances that raise substantial doubt about the going-concern assumption
The group (FIXER Inc.)
The on-premises generative AI service "Sovereign GaiXer," the cloud version "GaiXer," project-based services, generative AI services in the healthcare sector, the Yokkaichi Office, the Nagoya Office, and the Tokyo Head Office
The completion of some large-scale projects; delays in launching product development and the sales structure for "Sovereign GaiXer"; delays in fully launching sales of generative AI services in the healthcare sector; failure to achieve project-based service orders; and persistently high fixed costs due to insufficient reviews of staffing and the organisational structure
Operating loss of ¥2,316 million, ordinary loss of ¥2,310 million, net loss attributable to owners of the parent of ¥2,302 million, and negative operating cash flow of ¥2,239 million
Fiscal year ending August 2026 (1 September 2025–31 August 2026)
The company plans net sales of ¥3,381 million, an operating loss of ¥510 million, an ordinary loss of ¥505 million, and a net loss attributable to owners of the parent of ¥542 million for the fiscal year ending August 2027.
Company response
① Reduction of fixed costs and review of the management structure to align with the business scale; ② focused allocation of management resources and improvement of profitability; ③ management of the business plan and cash flow; and ④ initiatives to secure funding
The company will reduce fixed costs, review its management structure to align with the business scale, strengthen the sales structure and sales channels centred on "Sovereign GaiXer," manage the business plan and cash flow, and consider borrowings and other funding methods through discussions with financial institutions and other relevant parties.
| Item | Details |
|---|---|
| Event name | Events or circumstances that raise substantial doubt about the going-concern assumption |
| Date of occurrence | 31 August 2026 (end of the current consolidated fiscal year) |
| Subject Entity | The group (FIXER Inc.) |
| Target Locations / Products | The on-premises generative AI service "Sovereign GaiXer," the cloud version "GaiXer," project-based services, generative AI services in the healthcare sector, the Yokkaichi Office, the Nagoya Office, and the Tokyo Head Office |
| Cause | The completion of some large-scale projects; delays in launching product development and the sales structure for "Sovereign GaiXer"; delays in fully launching sales of generative AI services in the healthcare sector; failure to achieve project-based service orders; and persistently high fixed costs due to insufficient reviews of staffing and the organisational structure |
| Amount of Impact on Business Performance | Operating loss of ¥2,316 million, ordinary loss of ¥2,310 million, net loss attributable to owners of the parent of ¥2,302 million, and negative operating cash flow of ¥2,239 million |
| Accounting period in which recognized | Fiscal year ending August 2026 (1 September 2025–31 August 2026) |
| Impact on Earnings Forecast | The company plans net sales of ¥3,381 million, an operating loss of ¥510 million, an ordinary loss of ¥505 million, and a net loss attributable to owners of the parent of ¥542 million for the fiscal year ending August 2027. |
| Measures to prevent recurrence | ① Reduction of fixed costs and review of the management structure to align with the business scale; ② focused allocation of management resources and improvement of profitability; ③ management of the business plan and cash flow; and ④ initiatives to secure funding |
| Outlook | The company will reduce fixed costs, review its management structure to align with the business scale, strengthen the sales structure and sales channels centred on "Sovereign GaiXer," manage the business plan and cash flow, and consider borrowings and other funding methods through discussions with financial institutions and other relevant parties. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The completion of some large-scale projects; delays in launching the product development and sales structure for new businesses; delays in fully launching sales in the healthcare sector; failure to achieve project-based service orders; and persistently high fixed costs due to insufficient reviews of staffing and the organisational structure.